| Works Faster on Joint Pain | Better Pallatability |
|---|---|
 New UC-II randomized, double-blind, placebo-controlled study was conducted on healthy subjects. UC-II® provided significant results compared to placebo in increasing joint function. UC-II® consists of undenatured type II collagen, a FDA-notified and published new dietary ingredient (NDI). UC-II® is manufactured in a GMP-certified facility and has been determined GRAS for use in foods and beverages. |
 Maximus Joint UC-II® is now enriched with Lalmin Vit-RDA500 Europe, an elevated natural B-complex vitamin extracted from inactivated dried whole cell yeast (Saccharomyces cerevisiae). This new formulation is now non-artificially flavored. Provide the same dosage of fast pain relief and is small animal friendly. |
UC-II is sourced and manufactured in the United States. UC-II was determined GRAS in an intensive review of all safety and toxicology data by a panel of renowned United States scientific experts.
Derived from chicken sternum cartilage, UC-II® consists of undenatured type II collagen that supports joint comfort, flexibility and mobility.* UC-II is a FDA-notified and published new dietary ingredient. Supported by six animal clinical studies and backed by numerous patents, UC-II is the only source of undenatured type II collagen available as a powdered, shelf stable dietary ingredient.
Maximus Joint® (UC-II) Helps Slow Down the Joint Destructive Process
Maximus Joint® (UC-II) Allows Normal Cartilage Remodeling to Begin for Continued Joint Comfort.
Clinical Research
Numerous research studies in humans and different animal species have been conducted and published. The research path of UC-II began when researchers, including Harvard University Medical Center, found the benefits of undenatured type II collagen for joint health and published research in peer-reviewed journals. Since then, InterHealth has continued to systematically and methodologically build the research portfolio for UC-II.
Clinical Study on UC-II® ;
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis.
Efficacy and tolerability of UC-II as prevention against osteoarthritis.
Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee.
Comparison on efficacy of UC-II® compared to Glucosamine + Chondroitin on arthritic dog.
Better Joint Protection
UC-II, with clinical studies, shows to stop the host immune system from producing specific T-cells that attacks the joint.
Clinical Study on UC-II® ;
Pain reduction measured by ground force plate in arthritic dogs treated with type-II collagen.
Safety and toxicological evaluation of undenatured type II collagen.
X-ray with a comparison of bone structure since the time of the accident of a dog name - Chelsea, a Schnauzer.With UC-II® the bone structure is clearly redefined due to remineralization of the bone tissue.UC-II® is clearly proven in this case to stop joint degeneration,for treatment & prevention. 90% recovery in 150 days.
